摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N'-[3-(4-methoxyphenyl)propionyl]hydrazinecarboxylic acid n-propyl amide | 623176-91-0

中文名称
——
中文别名
——
英文名称
N'-[3-(4-methoxyphenyl)propionyl]hydrazinecarboxylic acid n-propyl amide
英文别名
1-[3-(4-Methoxyphenyl)propanoylamino]-3-propylurea
N'-[3-(4-methoxyphenyl)propionyl]hydrazinecarboxylic acid n-propyl amide化学式
CAS
623176-91-0
化学式
C14H21N3O3
mdl
——
分子量
279.339
InChiKey
KRJRDHQKLIVTHP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    79.5
  • 氢给体数:
    3
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N'-[3-(4-methoxyphenyl)propionyl]hydrazinecarboxylic acid n-propyl amide氢氧化钾 作用下, 以 甲醇 为溶剂, 反应 22.0h, 以75%的产率得到5-[2-(4-methoxyphenyl)ethyl]-4-propyl-2,4-dihydro-[1,2,4]triazol-3-one
    参考文献:
    名称:
    Design and Synthesis of a Potent and Selective Triazolone-Based Peroxisome Proliferator-Activated Receptor α Agonist
    摘要:
    A new series of hPPARalpha agonists containing a 2,4-dihydro-3H-1,2,4-triazol-3-one (triazolone) core is described leading to the discovery of 5 (LY518674), a highly potent and selective PPARalpha agonist.
    DOI:
    10.1021/jm034173l
  • 作为产物:
    参考文献:
    名称:
    Design and Synthesis of a Potent and Selective Triazolone-Based Peroxisome Proliferator-Activated Receptor α Agonist
    摘要:
    A new series of hPPARalpha agonists containing a 2,4-dihydro-3H-1,2,4-triazol-3-one (triazolone) core is described leading to the discovery of 5 (LY518674), a highly potent and selective PPARalpha agonist.
    DOI:
    10.1021/jm034173l
点击查看最新优质反应信息

文献信息

  • PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS
    申请人:Cano Ivan Collado
    公开号:US20090062358A1
    公开(公告)日:2009-03-05
    The present invention is directed to compounds represented by the following structural formula, and pharmaceutically acceptable salts, solvates and hydrates thereof, R1 is a substituted or unsubstituted group selected from C 1 -C 8 alkyl, aryl-C 0-2 -alkyl, heteroaryl-C 0-2 -alkyl, C3-C6 cycloalkylaryl-C 0-2 -alkyl or phenyl. W is O or S. R2 is H or a substituted or unsubstituted group selected from C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl and heteroaryl. X is a C 2 -C 5 alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S. Y is C, O, S, NH or a single bond. Furthermore, E is (CH 2 ) n COOH, wherein n is 0, 1, 2 or 3, or C(R3)(R4)A, wherein A is an acidic functional group such as carboxyl, carboxamide substituted or unsubstituted sulfonamide, or substituted or unsubstituted tetrazole. R3 is H, saturated or unsaturated C 1 -C 5 alkyl, C 1 -C 5 alkoxy. Additionally, R4 is H, halo, a substituted or unsubstituted group selected from C 1 -C 5 alkyl, C 1 -C 5 alkoxy, C 3 -C 6 cycloalkyl, arylC 0 -C 4 alkyl and phenyl, or R3 and R4 are combined to form a C 3 -C 4 cycloalkyl.
    本发明涉及以下结构式所代表的化合物,以及其药学上可接受的盐、溶剂合物和水合物,其中,R1是C1-C8烷基、芳基-C0-2-烷基、杂芳基-C0-2-烷基、C3-C6环烷基芳基-C0-2-烷基或苯基的取代或未取代基团。W为O或S。R2为H或C1-C6烷基、C3-C6环烷基和杂芳基的取代或未取代基团。X为C2-C5烷基链,在链中的一个碳原子可以被O、NH或S取代。Y为C、O、S、NH或单键。此外,E为(CH2)nCOOH,其中n为0、1、2或3,或C(R3)(R4)A,其中A为酸性功能基团,如羧基、羧酰基取代或未取代的磺酰胺基、取代或未取代的四唑基。R3为H、饱和或不饱和的C1-C5烷基、C1-C5烷氧基。此外,R4为H、卤素、C1-C5烷基、C1-C5烷氧基、C3-C6环烷基、芳基C0-C4烷基和苯基的取代或未取代基团,或R3和R4结合形成C3-C4环烷基。
  • US7304062B2
    申请人:——
    公开号:US7304062B2
    公开(公告)日:2007-12-04
  • Design and Synthesis of a Potent and Selective Triazolone-Based Peroxisome Proliferator-Activated Receptor α Agonist
    作者:Yanping Xu、Daniel Mayhugh、Ashraf Saeed、Xiaodong Wang、Richard C. Thompson、Samuel J. Dominianni、Raymond F. Kauffman、Jaipal Singh、James S. Bean、William R. Bensch、Robert J. Barr、John Osborne、Chahrzad Montrose-Rafizadeh、Richard W. Zink、Nathan P. Yumibe、Naijia Huang、Debra Luffer-Atlas、Deepa Rungta、Dale E. Maise、Nathan B. Mantlo
    DOI:10.1021/jm034173l
    日期:2003.11.1
    A new series of hPPARalpha agonists containing a 2,4-dihydro-3H-1,2,4-triazol-3-one (triazolone) core is described leading to the discovery of 5 (LY518674), a highly potent and selective PPARalpha agonist.
查看更多